IKT
Inhibikase Therapeutics, Inc. Common StockstockNASDAQ
At CloseNov 19, 2026 3:59:55 PM EST
1.30USD-5.435%(-0.08)495,646
After-hoursNov 19, 2026 4:00:30 PM EST
1.30USD-0.383%(-0.00)
IKT Financials
In Q3 FY 2026 (ended ), Inhibikase Therapeutics, Inc. Common Stock (IKT) reported net income of −$20.47M, operating cash flow of −$17.35M, and assets of $201.75M (filed ).
Loading financial statements…